Evidence map›Paper›PMID 42329361›Full record

ArticleJournal of clinical laboratory analysis2026

Reference Interval Establishment for Four Coagulation Parameters Using Indirect Methods in a High-Altitude Chinese Population: A Retrospective Real-World Analysis.

Banjiu Zhaxi, Danni Mu, Shengfang Ye, Chaochao Ma, Zhen Da, Yichen Ma, Yumeng Gao, Shensong Li, Yixicuomu, Zhaxiyangzong and 6 more

Abstract read
In one paragraph

Article in Journal of clinical laboratory analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Banjiu ZhaxiDepartment of Laboratory Medicine, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Science, Beijing, China.
Danni MuDepartment of Laboratory Medicine, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Science, Beijing, China.
Shengfang YeDepartment of Clinical Laboratory, People's Hospital of Tibet Autonomous Region, Lhasa, China.
Chaochao MaDepartment of Laboratory Medicine, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Science, Beijing, China.
Zhen DaDepartment of Clinical Laboratory, People's Hospital of Tibet Autonomous Region, Lhasa, China.
Yichen MaDepartment of Laboratory Medicine, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Science, Beijing, China.
Yumeng GaoDepartment of Laboratory Medicine, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Science, Beijing, China.
Shensong LiDepartment of Clinical Laboratory, People's Hospital of Tibet Autonomous Region, Lhasa, China.
YixicuomuDepartment of Clinical Laboratory, People's Hospital of Tibet Autonomous Region, Lhasa, China.
ZhaxiyangzongDepartment of Clinical Laboratory, People's Hospital of Tibet Autonomous Region, Lhasa, China.
Jinrong PangDepartment of Clinical Laboratory, People's Hospital of Tibet Autonomous Region, Lhasa, China.
Mingjun ZhanDepartment of Clinical Laboratory, People's Hospital of Tibet Autonomous Region, Lhasa, China.
Ling QiuDepartment of Laboratory Medicine, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Science, Beijing, China.
Qu DanDepartment of Clinical Laboratory, People's Hospital of Tibet Autonomous Region, Lhasa, China.
Xinqi ChengDepartment of Laboratory Medicine, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Science, Beijing, China.ORCID https://orcid.org/0000-0001-8228-5078
Zhijuan LiuDepartment of Clinical Laboratory, People's Hospital of Tibet Autonomous Region, Lhasa, China.

Funding

National Key Technologies R&D Program provided by Ministry of Science and Technology of the People's Republic of China 2022YFC3602300National Key Technologies R&D Program provided by Ministry of Science and Technology of the People's Republic of China 2022YFC3602302National Natural Science Foundation of China 72274218Natural Science Foundation of Tibet Autonomous Region organized medical aid project ZX2022ZR-ZY12(Z)
6 · The paper itself

Abstract

objectivesThis study utilized two indirect methods to establish reference intervals (RIs) for four coagulation parameters for the adult population in Tibet, a high-altitude region in Western China.

methodsCoagulation Data, Including Activated Partial Thromboplastin Time (APTT), prothrombin Time (PT), thrombin Time (TT), and Fibrinogen (FIB) Obtained From the People's Hospital of Tibet Autonomous Region Between 2019 and 2023, Were Subjected to Box-Cox Transformation for Normalization and Tukey Method for Outlier Removal. the RIs Were Calculated Using Hoffmann and refineR Methods, Respectively.

resultsA total of 5086, 5282, 5386, and 5377 test results for APTT, PT, TT, and FIB were included. The Hoffmann and refineR method yielded the following total RIs: APTT 30.54-46.32 and 30.14-44.30 s; PT 10.54-14.51 and 10.32-13.89 s; TT 14.92-19.46 and 14.88-18.93 s; FIB 2.05-4.68 and 2.02-4.40 g/L, respectively. Gender-partitioned RIs were calculated for all four parameters, while age-partitioned RIs were specifically calculated for PT and FIB based on bias ratio values. The lower limits of RIs estimated by the two methods remained consistent. The established RIs for APTT and FIB were significantly higher than those utilized in the plain area and those provided by the manufacturer, whereas the established RIs of TT were significantly lower.

conclusionThe RIs for coagulation parameters in the population living on the Tibetan Plateau exhibited significant divergence from those utilized in the plain area. Specific RIs for high-altitude regions should be established to accurately evaluate the presence of coagulation disorders.

Indexed as

AltitudeBlood CoagulationAdultAgedBlood Coagulation TestsEast Asian PeopleFemaleFibrinogenHumansMaleMiddle AgedPartial Thromboplastin TimeProthrombin TimeReference ValuesRetrospective StudiesThrombin TimeFibrinogencoagulationhypoxiaindirect methodreference intervalTibet

Identifiers

PMID42329361
PMCPMC13399815

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.